Chimerix Inc. (NASDAQ: CMRX) stock closed at 2.06 per share at the end of the most recent trading day (a 13.19% change compared to the prior day closing price) with a volume of 24.35M shares and market capitalization of 180.12M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 43 people. Chimerix Inc. CEO is Michael Sherman.

The one-year performance of Chimerix Inc. stock is -76.55%, while year-to-date (YTD) performance is -67.96%. CMRX stock has a five-year performance of -61.85%. Its 52-week range is between 1.27 and 8.78, which gives CMRX stock a 52-week price range ratio of 10.52%

Chimerix Inc. currently has a PE ratio of -1.40, a price-to-book (PB) ratio of 2.93, a price-to-sale (PS) ratio of 225.24, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -93.43%, a ROC of -108.03% and a ROE of -115.62%. The company’s profit margin is -%, its EBITDA margin is -17 996.10%, and its revenue ttm is $559.00 Thousand , which makes it $0.01 revenue per share.

Of the last four earnings reports from Chimerix Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.24 for the next earnings report. Chimerix Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Chimerix Inc. is Strong Buy (1), with a target price of $8.75, which is +324.76% compared to the current price. The earnings rating for Chimerix Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Chimerix Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Chimerix Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 16.61, ATR14 : 0.26, CCI20 : 156.28, Chaikin Money Flow : 0.01, MACD : -0.33, Money Flow Index : 75.44, ROC : 10.16, RSI : 49.41, STOCH (14,3) : 65.83, STOCH RSI : 1.00, UO : 49.51, Williams %R : -34.17), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Chimerix Inc. in the last 12-months were: David Jakeman (Sold 7 890 shares of value $46 767 ), Fred A. Middleton (Buy at a value of $95 157), Martha J. Demski (Buy at a value of $16 100), Michael T. Andriole (Buy at a value of $25 635), Robert J. Meyer (Buy at a value of $23 470)